TAP - Toumpoulis Aneurysm Prognosis(TAP is a medical device undergoing IVDR CE certification. Not for sale)
The first diagnostic and prognostic blood test, based in mRNA and RT-qPCR technology for the human aortic aneurysm, both thoracic and abdominal.
Instructions for UsePlease fill in the fields below, to get access to the instruction manual of TAP
Early detection saves lives as aneurysms most often times can be treated
Our blood test can be used repeatedly used, without negative consequences for the patient, monitoring the disease and providing clear results about it's progress.
A silent killer
The aneurysm can suddenly break and most of the time the patient dies due to massive internal bleeding.
It is calculated that around 1% – 2% of the population has aortic aneurysm most of them are being undiagnosed.
The disease does not have any early symptoms.